NEW YORK: Medical Marijuana Inc. (OTC Pink: MJNA) today announced that their subsidiary company, Canipa Holdings, has signed an exclusive worldwide distribution and marketing agreement with a prominent European-based pharmaceutical/ nutraceutical/cosmetics company.
Canipa Holdings will manage the marketing and distribution of the European company’s portfolio of over twenty hemp-based consumer products. The products will be added to the HempMedsPX platform.
Some of the products Canipa Holdings will be marketing and selling are approved for specific medical claims in parts of the European market, says Charles Vest, Director of Communications for HempMedsPX, the marketing company for Medical Marijuana Inc. and all MJNA subsidiarycompanies. We want to make clear, however, that these products will be marketed as consumer-only in the United States and its territories.
In the largest transaction that the company has signed to date, Canipa Holdings has also acquired the exclusive online marketing and sales rights for this new portfolio of hemp-based products (excluding The Middle East, Poland, Czech Republic, Hungary, Slovakia, and Latvia). Finally, Canipa Holdings will be the exclusive retail store/brick-and-mortar distributor for these new hemp-based products in all United States and territories as well as Canada and Mexico. The company will seek to negotiate additional territories as markets become viable.
Nothing like these products exist today, continues Vest. The European Union (EU), through the European Medicines Agency, is already well aware of the potential health and wellness applications for hemp-based products, evidenced by the fact that this new product portfolio that Canipa has acquired is marketed for specific ailments in parts of the EU.